|
PresVIEW™ and Presbyopia
Refocus Group's Mission is to Become a Surgical Standard of Care for the Treatment of Presbyopia Worldwide.
Note: The company’s primary product, the PresVIEW™ Scleral Implant, is an investigational device and is not yet approved for sale or use in the United States or Canada. However, the product is currently approved for sale in the European Union.
|
 |
| Patients Click This Image! |
|
|
 |
| Professionals Click This Image! |
|
|
|
